Funding Opportunities
Check back frequently to learn about emerging energy balance-related funding opportunities!
Cancer Prevention Research Institute of Texas
American Cancer Society (ACS)
Patient-Centered Outcomes Research Institute (PCORI)
Engagement Award: Knowledge, Training and Development, and Dissemination Awards
Federal Grants
- Exploratory/Developmental Clinical Research Grants in Obesity
- Institutional Network Award for Promoting Kidney, Urologic, and Hematalogic Research Training (U2C-Clinical Trial Not Allowed)
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)
- Notice of Special Interest (NOSI): Obestiy Policy Evaluation Research (R01 - Clinical Trial Not Allowed)
- Mechanisms and Consequences of Sleep Disparities in the U.S. (R01 - Clinical Trial Not Allowed)
- Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
- Notice of Special Interest (NOSI): Improving Methods to Assess Body Composition in Infants and Young Children
- Notice of Special Interest (NOSI): Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Health Disparity Populations
- Limited Competition: Childhood Cancer Survivor Study (U24 Clinical Trial Required)
- NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)
- NLM Information Resource Grants to Reduce Health Disparities (G08 Clinical Trial Not Allowed)
- Notice of Special Interest: Administrative Supplements to Support Emerging Physician-Scientists to Develop Research Expertise in Diabetes, Endocrinology and Metabolic Diseases
- Planning Projects for Clinical Trials on Effects of Sustained Reductions in Caloric Intake and Related Dietary Practices in Younger and Older Persons (U01 Clinical Trial Optional)
- NCMRR Early Career Research Award (R03 Clinical Trial Optional)
Because obesity has been observed to be associated with increased incidence and mortality of certain cancers, including postmenopausal breast, pancreatic, ovarian, and colorectal cancer, among others, the National Cancer Institute (NCI) will participate in this initiative. The NCI believes it is particularly important to foster research to identify effective interventions for prevention and treatment of obesity, including novel energy intake and expenditure modalities that alter body weight and/or composition in certain subpopulations of cancer patients and those at high risk for cancer. Thus, the types of research applications which NCI is interested in supporting include pilot human intervention studies utilizing bioactive components (e.g., tea polyphenols, calcium), or variation in diet composition or dietary pattern strategies that evaluate weight change in populations of interest to NCI. Such populations might include individuals with a genetic propensity for cancer as well as those with cancer or those at risk for recurrence of cancer. Studies that target ethnic and minority populations are also encouraged. NCI is also interested in pilot intervention studies that examine the influence of weight loss/control on cancer related biomarkers.
- Pre-Application for Collaborative Innovation Award, CTSA Program
- Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program
- PAR-19-099 (U01)
- Standard dates apply for both
- Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival
- Time-Sensitive Obesity Policy and Program Evaluation
- PAR-18-854 (R01)
- Standard dates apply
- Testing Intervention for Health-Enhancing Physical Activity
- PAR-18-324 (R01)
- Standard dates apply
- Developing Interventions for Health-Enhancing Physical Activity
- PAR-18-307 (R21/R33)
- Standard dates apply
- National Cancer Institute Program Project Applications
- PAR-16-457 (P01)
- Standard dates apply
- Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research
- PA-18-902 (R01)
- Standard dates apply
- Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional)
- PAR-20-180 (R01)
- Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed)
- Exploratory/Developmental Grants Program for Basic Research in Cancer Health Disparities
- PAR-18-655
- **Notice of Extension of Expiration Date**
- PAR-18-655
- Research in Cancer Health Disparities
- PAR-18-655
- **Notice of Extension of Expiration Date**